Late clinical outcome after successful radiofrequency catheter ablation of accessory pathways

J Schläpfer1, M Fromer

  • 1Division of Cardiology, University Hospital, Lausanne, Switzerland.

European Heart Journal
|March 22, 2001
PubMed

Insights

Radiofrequency catheter ablation for accessory pathway tachycardia shows a low 4% long-term recurrence rate. Most patients remain symptom-free long after the procedure for drug-resistant tachycardia.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Accessory pathway-mediated tachycardia is a common cause of symptomatic arrhythmias.
  • Drug-resistant cases often require invasive treatment like radiofrequency catheter ablation.

Purpose of the Study:

  • To evaluate the long-term clinical outcomes of radiofrequency catheter ablation for symptomatic accessory pathway-mediated tachycardia.
  • To determine the recurrence rate and causes of symptoms post-ablation.

Main Methods:

  • A cohort of 180 patients with drug-resistant accessory pathway tachycardia underwent successful radiofrequency catheter ablation.
  • Clinical follow-up was conducted via direct contact with patients and physicians for a median of 48.1 months.

Main Results:

  • Seven procedure-related complications (4%) occurred.
  • 79% of patients remained asymptomatic during follow-up.
  • Recurrence of accessory pathway tachycardia was observed in 4% of patients, typically within the first month post-ablation.

Conclusions:

  • Radiofrequency catheter ablation offers a low long-term recurrence rate for accessory pathway-mediated tachycardia.
  • Late-onset symptoms (after 3 months) are more likely due to supraventricular arrhythmias from other causes, not accessory pathway recurrence.
Abstract